publicli
fund
repositori
covid
databas
right
unrestrict
research
reus
analys
form
mean
acknowledg
origin
sourc
permiss
grant
free
elsevi
long
resourc
centr
remain
activ
veterinari
microbiolog
increas
litter
surviv
rate
reduc
clinic
ill
better
lactogen
immun
tgev
gilt
prime
neonat
porcin
respiratori
coronaviru
prcv
establish
immunolog
memori
femal
piglet
young
age
prcv
effect
induc
secondari
immun
respons
limit
dose
virul
tgev
given
oral
day
prior
farrow
subsequ
passiv
antibodi
transfer
offspr
prime
gilt
effici
surviv
lethal
tgev
challeng
averag
surviv
rate
occur
litter
piglet
prime
gilt
boost
plaqu
form
unit
pfu
tgev
wherea
piglet
surviv
three
litter
suckl
prime
gilt
boost
pfu
tgev
nonprim
gilt
given
ident
prefarrow
dose
tgev
litter
surviv
rate
respect
moreov
group
litter
prime
gilt
suffer
less
clinic
ill
measur
extent
weight
loss
postchalleng
control
litter
prime
piglet
neonat
boost
pregnant
gilt
produc
anamnest
system
immun
respons
correspondingli
higher
milk
titer
prime
gilt
compar
control
anim
thu
prime
piglet
prcv
benefici
provid
resist
tgev
could
incorpor
vaccin
strategi
yield
better
protect
tgev
transmiss
gastroenter
viru
tgev
replic
destroy
matur
absorpt
epitheli
cell
small
intestin
caus
villou
atrophi
enter
moon
tge
often
fatal
young
suckl
pig
limit
nutrient
reserv
villu
enterocyt
slow
regener
moon
et
al
matur
pig
except
perhap
pregnant
dam
tgev
infect
subclin
occasion
soft
fece
may
observ
site
tgev
replic
includ
respiratori
tract
mammari
gland
viru
easili
isol
intestin
content
fece
saif
bohl
saif
wesley
pregnant
sow
gilt
vaccin
tge
either
prophylact
acut
diseas
outbreak
order
passiv
immun
suckl
piglet
ingest
colostrum
postparturi
milk
contain
protect
tgev
antibodi
hooper
haelterman
ingest
colostr
milk
antibodi
neutral
tgev
thu
protect
suscept
epitheli
cell
small
intestin
term
lactogen
immun
haelterman
frequent
nurs
piglet
ensur
plenti
suppli
passiv
antibodi
neutral
viru
sow
gilt
infect
virul
tgev
develop
suffici
matern
antibodi
iga
igg
protect
nearli
offspr
stone
et
al
efficaci
attenu
tge
vaccin
less
effici
saif
wesley
moreov
dose
virul
viru
import
establish
adequ
lactogen
immun
wesley
contrast
tgev
porcin
respiratori
coronaviru
prcv
isol
readili
upper
lower
respiratori
tract
littl
viru
replic
occur
intestin
tract
prc
virus
spontan
delet
mutant
tgev
delet
occur
frequenc
europ
north
america
sinc
pensaert
et
al
wesley
et
al
britton
et
al
vaughn
et
al
kim
et
al
notabl
chang
tgev
prcv
larg
delet
ntermin
portion
prcv
spike
glycoprotein
lead
truncat
protein
may
account
differ
tissu
tropism
virus
krempl
et
al
sanchez
et
al
antigen
site
prcv
protein
remain
unchang
tgev
protein
infect
pig
prcv
induc
similar
neutral
antibodi
titer
prcv
tgev
term
cross
protect
pig
infect
prcv
result
inconsist
one
studi
use
specif
pathogen
free
spf
pig
prior
infect
prcv
caus
reduct
amount
durat
shed
tgev
van
nieuwstadt
et
al
contrast
prcv
infect
wean
pig
similar
age
show
prcvprime
humor
local
immun
system
tgev
secondari
antibodi
respons
induc
tgev
challeng
cox
et
al
sinc
young
piglet
suscept
tgev
heighten
immun
therefor
would
benefici
litter
prime
femal
pig
thu
purpos
studi
measur
increas
protect
passiv
immun
tgev
gilt
prime
prcv
neonat
wesley
prcvprime
gilt
boost
low
oral
dose
tgev
dose
insuffici
provid
complet
protect
wesley
day
prior
farrow
secondari
antibodi
respons
milk
titer
measur
also
litter
prime
boost
gilt
challeng
tgev
clinic
sever
diseas
percentag
surviv
piglet
determin
piglet
princip
born
nation
anim
diseas
center
nadc
serolog
neg
sow
prior
infect
princip
serolog
neg
tgevprcv
serum
neutral
sn
antibodi
day
age
infect
intranas
plaqu
form
unit
pfu
avirul
prcv
strain
wesley
prcvprime
femal
piglet
maintain
isol
room
week
commingl
singl
outsid
pen
agematch
control
femal
anoth
litter
serolog
statu
pig
follow
matur
bred
tgevprcv
serolog
neg
boar
wesley
experiment
design
use
princip
stimul
lactogen
immun
exposur
low
oral
dose
tgev
farrow
determin
whether
litter
prcvprime
gilt
better
abl
resist
surviv
challeng
exposur
tgev
approxim
week
farrow
nine
prime
three
control
gilt
plu
five
control
gilt
purchas
outsid
commerci
sourc
one
control
first
pariti
sow
brought
isol
barn
nadc
farrow
dam
bled
day
farrow
tabl
given
low
dose
virul
tgev
miller
strain
pigpassag
either
booster
dose
case
prime
pig
initi
dose
case
control
anim
tge
stock
viru
pfuml
dilut
modifi
eagl
minim
essenti
medium
emem
contain
fetal
bovin
serum
fb
gilt
inocul
ml
ml
given
oral
ml
given
nostril
two
differ
dose
tgev
use
six
prime
gilt
six
control
gilt
inocul
pfu
tgev
higher
dose
three
prime
gilt
three
control
two
gilt
first
pariti
sow
given
pfu
tgev
lower
dose
minim
dose
stimul
lactogen
immun
wesley
day
inocul
daili
day
bodi
temperatur
determin
rectal
swab
taken
anim
also
dam
monitor
twice
daili
clinic
sign
includ
chang
stool
consist
inappet
serum
sampl
dam
milk
collect
day
postfarrow
sera
milk
also
collect
day
day
piglet
challeng
tgev
nurs
piglet
bled
prior
tgev
challeng
order
determin
matern
antibodi
level
transfer
dam
day
age
piglet
challeng
approxim
piglethaldos
virul
miller
strain
tgev
frozen
aliquot
challeng
viru
thaw
dilut
phosphat
buffer
salin
viru
sonic
briefli
disrupt
viral
aggreg
sonic
challeng
viru
dilut
emem
supplement
fb
final
dilut
piglet
challeng
ml
dilut
tgev
directli
stomach
via
stomach
tube
start
day
age
piglet
weigh
daili
challeng
consecut
day
challeng
exposur
piglet
observ
three
time
daili
clinic
sign
postchalleng
exposur
interv
day
use
determin
pig
surviv
rate
milk
whey
serum
sampl
dam
heat
inactiv
tgevprcv
neutral
antibodi
titer
determin
plaquereduct
test
use
swine
testicular
st
cell
attenu
plaquepurifi
miller
strain
tgev
pass
twice
st
cell
use
assay
approxim
pfu
attenu
tgev
incub
h
c
dilut
test
sampl
inocul
overlay
st
cell
viru
neutral
vn
antibodi
titer
express
reciproc
highest
dilut
produc
reduct
plaqu
sera
piglet
also
heat
inactiv
tgevprcv
neutral
antibodi
titer
determin
vn
test
use
flatbottom
microtit
plate
confluent
st
cell
paton
et
al
twofold
serum
dilut
test
use
four
well
per
dilut
incub
plate
day
c
humidifi
co
atmospher
cell
fix
methanol
stain
crystal
violet
serum
neutral
titer
determin
spearmankarb
method
dilut
serum
neutral
attenu
tgev
well
rectal
swab
sampl
collect
dam
prior
give
prefarrow
dose
tgev
either
booster
initi
dose
day
follow
tgev
exposur
rectal
swab
place
ml
cold
emem
supplement
fb
penicillin
uml
streptomycin
ugml
neomycin
sulfat
ugml
bacitracin
uml
gentamicin
sulfat
ugml
store
frozen
c
swab
sampl
thaw
squeez
steril
forcep
centrifug
c
microcentrifug
min
remov
debri
reduc
bacteri
load
two
hundr
microlit
sampl
supernat
appli
confluent
st
cell
plate
inoculum
remov
h
ml
per
well
emem
contain
fb
antibiot
concentr
list
porcin
antisera
enteroviru
rotaviru
fungizon
gml
ad
plate
incub
c
humidifi
co
incub
observ
light
microscopi
cytopath
effect
cpe
day
swab
sampl
pass
total
three
time
st
cell
ensur
detect
tgev
posit
control
test
pfu
virul
tgev
l
use
confirm
sensit
st
cell
miller
gut
viru
one
sampl
caus
cpe
confirm
tgev
use
indirect
fluoresc
antibodi
test
tgevspecif
monoclon
antibodi
surviv
rate
group
piglet
analyz
comput
chisquar
statist
litter
size
fix
method
rao
scott
use
account
litter
size
variat
effect
adjust
underli
sampl
size
differ
p
consid
signific
thirteen
day
farrow
tabl
prime
gilt
control
gilt
given
virul
tgev
stimul
lactogen
immun
previou
experi
determin
low
oral
dose
tgev
adequ
stimul
lactogen
immun
control
gilt
provid
limit
protect
litter
wesley
time
prefarrow
dose
given
control
anim
neg
tgevprcv
neutral
antibodi
prime
gilt
seroneg
prime
gilt
low
sn
titer
less
wesley
follow
exposur
tgev
mani
gilt
went
offfe
day
anim
transient
soft
fece
transient
diarrhea
higher
dose
pfu
dose
tgev
prime
gilt
three
six
control
gilt
feed
three
prime
gilt
two
control
gilt
soft
stool
diarrhea
similarli
lower
dose
pfu
tgev
prime
gilt
appear
sensit
tgev
control
anim
two
three
prime
gilt
went
feed
wherea
none
gilt
first
pariti
sow
given
lower
dose
feed
anim
given
lower
dose
tgev
show
sign
diarrhea
soft
fece
furthermor
bodi
temperatur
rectal
swab
taken
daili
prime
control
anim
period
follow
exposur
tgev
none
anim
febril
tgev
recov
one
fecal
sampl
singl
day
day
postexposur
viru
recoveri
prime
gilt
given
lower
dose
tgev
show
sign
diarrhea
tgev
recov
rectal
swab
control
gilt
sera
milk
collect
prime
control
gilt
day
postfarrow
repres
rang
day
exposur
tgev
geometr
mean
sn
antibodi
titer
geometr
mean
vn
antibodi
titer
milk
group
gilt
summar
fig
titer
demonstr
prime
gilt
anamnest
immun
respons
booster
dose
tgev
compar
control
gilt
given
prefarrow
dose
initi
exposur
geometr
mean
sn
titer
greater
prime
versu
control
anim
averag
group
gilt
given
either
higher
lower
dose
tgev
milk
vn
titer
show
trend
differ
prime
control
gilt
less
high
dose
averag
increas
low
dose
increas
milk
vn
titer
prime
gilt
compar
geometr
mean
valu
control
gilt
also
dose
effect
base
exposur
tgev
prime
control
group
gilt
given
higher
dose
tgev
induc
higher
level
neutral
antibodi
averag
correspond
group
given
lower
dose
postfarrow
day
sn
milk
vn
titer
compar
postchalleng
sn
milk
vn
titer
day
postchalleng
determin
dam
reinfect
contact
exposur
tgev
challeng
litter
prime
anim
given
either
high
low
dose
sn
milk
vn
titer
lower
day
postchalleng
indic
resist
reinfect
data
shown
result
control
gilt
variabl
six
control
gilt
given
higher
dose
three
sn
titer
decreas
postchalleng
two
increas
one
stay
high
dose
control
gilt
four
milk
vn
titer
decreas
two
stay
unchang
term
sn
titer
three
low
dose
control
two
increas
postchalleng
one
unchang
wherea
milk
vn
titer
one
decreas
one
increas
one
remain
unchang
matern
antibodi
passiv
transfer
absorb
piglet
h
farrow
roth
sn
titer
day
postfarrow
determin
piglet
prior
challeng
tgev
geometr
mean
titer
litter
determin
fig
show
averag
standard
deriv
sn
titer
group
litter
high
low
dose
prime
control
gilt
result
similar
gilt
sn
titer
fig
litter
high
dose
prime
gilt
highest
geometr
mean
titer
follow
litter
low
dose
prime
gilt
litter
control
gilt
given
higher
dose
final
litter
control
gilt
given
low
dose
geometr
mean
sn
titer
litter
prime
control
gilt
show
vari
degre
enter
ill
follow
challeng
tgev
individu
piglet
weigh
day
postchalleng
monitor
sever
clinic
infect
recoveri
infect
averag
weight
litter
calcul
averag
daili
weight
show
litter
prime
gilt
given
high
booster
dose
outperform
litter
prime
gilt
given
lower
dose
group
litter
prime
gilt
outperform
correspond
control
litter
fig
litter
high
dose
prime
gilt
averag
gain
weight
day
challeng
lost
weight
day
began
recov
day
high
low
dose
control
litter
litter
prime
gilt
given
low
booster
dose
show
much
sever
weight
loss
averag
litter
high
dose
prime
gilt
tabl
show
surviv
rate
litter
experiment
group
litter
prime
gilt
boost
high
dose
greatest
percent
survivor
surviv
rate
group
significantli
improv
p
compar
high
dose
control
group
even
account
litter
size
variat
rao
scott
low
dose
prime
gilt
next
best
surviv
rate
follow
control
group
expos
either
high
prefarrow
dose
surviv
low
prefarrow
dose
latter
group
consist
litter
three
dam
two
good
surviv
valu
wherea
one
litter
first
pariti
sow
markedli
reduc
averag
surviv
rate
group
serolog
data
indic
clearli
prime
femal
piglet
exposur
prcv
effect
establish
protect
immunolog
memori
tgev
immunolog
memori
last
least
first
parturit
pig
year
shown
anamnest
sn
antibodi
respons
enhanc
lactogen
respons
group
prime
gilt
antibodi
measur
milk
total
vn
antibodi
specif
measur
siga
made
prime
gilt
given
either
booster
dose
greater
increas
sn
titer
comparison
correspond
control
group
likewis
anamnest
vn
respons
milk
titer
prime
gilt
increas
less
sn
titer
averag
increas
milk
vn
titer
prime
gilt
compar
primari
vn
respons
milk
control
dam
moreov
prime
gilt
better
immun
sinc
effici
resist
reinfect
tgev
due
contact
exposur
tgev
challeng
litter
prime
gilt
show
seroconvers
day
postchalleng
wherea
control
dam
variabl
result
declin
titer
other
stabl
increas
titer
due
reinfect
thu
infect
young
pig
prcv
immunolog
memori
induc
long
last
benefici
protect
pig
piglet
tgev
one
possibl
neg
aspect
immunolog
memori
prime
gilt
appear
pronounc
clinic
sign
oral
dose
tgev
control
dam
observ
simpli
could
error
limit
number
anim
studi
inde
previou
experi
nonprim
gilt
experienc
inappet
diarrhea
given
tgev
inoculum
similar
dose
rang
wesley
moreov
pig
recov
tgev
resist
subsequ
reinfect
viru
thu
lack
clinic
sign
cox
et
al
vancott
et
al
saif
wesley
howev
durat
resist
report
approxim
time
interv
use
studi
perhap
one
possibl
prcvprime
gilt
booster
dose
tgev
may
addit
inflammatori
compon
intestin
tract
result
appar
clinic
sign
regard
respiratori
infect
prcv
shown
stimul
antibodi
secret
cell
local
respiratori
tract
also
lodg
gut
associ
lymphoid
tissu
vancott
et
al
previou
studi
prcv
use
inocul
piglet
induc
activ
immun
wesley
wood
clinic
sign
respiratori
diseas
observ
neonat
anim
transient
reduc
weight
gain
piglet
partial
protect
immun
establish
day
sn
antibodi
also
detect
day
postexposur
prcv
current
studi
neonat
piglet
infect
similarli
prcv
sn
titer
prime
pig
decay
cours
year
follow
infect
pig
immunolog
memori
sinc
develop
secondari
immun
respons
booster
exposur
tgev
transfer
passiv
protect
antibodi
offspr
addit
lanza
et
al
sestak
et
al
shown
prcv
induc
immunolog
memori
older
pig
sow
studi
immun
prcv
prior
first
parturit
second
parturit
sow
retain
immunolog
memori
secondari
humor
lactogen
immun
respons
particularli
increas
siga
yield
better
protect
tgev
challeng
offspr
immunolog
prime
common
immun
system
prcv
report
wean
spf
pig
wean
pig
convent
rais
van
nieuwstadt
et
al
cox
et
al
studi
prime
follow
week
later
virul
challeng
tgev
anamnest
humor
immun
respons
occur
latter
studi
intestin
siga
respons
prcv
immun
pig
suggest
local
secondari
immun
occur
intestin
mucosa
either
complet
block
tgev
shed
pig
reduc
durat
shed
pig
litter
surviv
rate
quit
variabl
uncommon
tgev
challeng
experi
suckl
piglet
litter
prcvprime
gilt
percent
surviv
rang
higher
dose
three
litter
lower
dose
surviv
rate
correspond
control
litter
rang
higher
dose
lower
dose
chisquar
probabl
distribut
use
evalu
overal
surviv
percentag
even
litter
size
variat
taken
account
rao
scott
overal
percent
surviv
litter
prcvprime
gilt
signific
p
compar
surviv
rate
correspond
control
litter
contrast
lower
booster
dose
pfu
surviv
rate
litter
prime
versu
control
gilt
signific
p
conclus
prcv
prime
immun
respons
tgev
current
studi
immunolog
memori
occur
gilt
prime
prcv
even
young
piglet
thu
prime
dam
threshold
tgev
need
induc
protect
immun
offspr
lower
like
even
commerci
modifiedl
tgev
vaccin
given
oral
prcvprime
gilt
would
provid
superior
protect
offspr
via
lactogen
immun
